Since the peak of the AIDS epidemic, the U.S. has achieved significant advancements in preventing and treating HIV, though progress has been uneven across regions and slower than necessary. In Missouri, where the number of new HIV diagnoses and deaths has not improved since 2017, there is a need to recapture momentum in addressing the disease.
In a bid to jump-start the stalled campaign against HIV in the region, researchers at Washington University School of Medicine in St. Louis and Saint Louis University plan to establish the Midwest Developmental Center for AIDS Research with funding from the National Institutes of Health (NIH). The center, slated to open in September, will aim to create a platform for researchers and public health workers to collaborate and coordinate their efforts to fight the HIV epidemic together.
“There’s a public perception that we’re on the other side of the HIV epidemic,” said Elvin Geng, MD, a Washington University professor of medicine who will direct the new center. “St. Louis continues to have a significant HIV epidemic. One problem we face here in St. Louis is that the scientific and public health communities are strong but siloed. The goal of this center is to break down those siloes so we can all work together more effectively to end the HIV epidemic in the region.”
Every year, about 500 people are newly diagnosed with HIV in Missouri, and nearly 200 die of disease related to HIV infection. Thirteen of the U.S. counties identified by the Centers for Disease Control and Prevention to be at highest risk of an HIV outbreak are in Missouri. Most people in the state get diagnosed late in the disease process, after their immune cells have begun to die off. This pattern of late diagnosis suggests that the official numbers probably underestimate the true infection rate in the state. Worse, it means that many people who could benefit from HIV treatment are not receiving it, which threatens their health and hinders efforts to limit the spread of the virus.
The NIH established the Centers for AIDS Research (CFAR) program in 1988 to promote high-quality research to combat the AIDS epidemic, which was then raging out of control. Over the years, 19 CFARs have been established throughout the country. The new center in St. Louis is a developmental CFAR, meaning it is in a five-year initiation phase.
“This center is built on collaboration between our regional universities,” said Enbal Shacham, PhD, a professor of behavioral science and health equity at Saint Louis University and the associate director of the center. “It will focus our efforts to grow research on HIV prevention, care and treatment to our St. Louis region together. I am thrilled to lead the Saint Louis University partnership particularly because of the opportunities this creates for our communities in improving HIV-related health equity and outcomes.”
The mission of the CFAR program is to provide a framework to bring the people who conduct the research into conversation with the people who are fighting the epidemic on the ground. To that end, Geng and center co-director Juliet Iwelunmor, PhD, a professor of medicine at Washington University, have pulled together a stakeholder advisory committee including representatives from the city and state health departments, as well as from Fast-Track Cities St. Louis, the local branch of an international campaign to end the HIV/AIDS epidemic by 2030, and the Metro St. Louis HIV Health Services Planning Council. The center will institute a variety of programs to enhance collaboration including:
- Show Me the Response, an annual regional symposium that will give scientists and public health practitioners the opportunity to meet in person and share data and insights.
- Partner Pilot Awards, which will go to research teams co-led by investigators from traditional research universities and nonresearch organizations.
- Internship opportunities at the city’s Department of Health for students from Harris-Stowe State University, a historically Black university.
“The Midwest Center for AIDS Research will help diversify the approach to, and the leaders engaged in, efforts to mitigate the AIDS epidemic,” said Harvey R. Fields Jr., PhD, dean of the College of STEM at Harris-Stowe. “The inclusion of Harris-Stowe State University leverages institutional strengths, enhances institutional capability and provides Harris-Stowe’s developing health-care scholars with opportunity to make meaningful contributions to their own communities even as undergraduates.”
In addition, the center will participate in the STAR (Stimulating Training and Access to HIV Research Experiences) program, an innovative, multicenter, yearlong educational program that aims to develop the next generation of HIV research leaders by training undergraduate and graduate students in problem-based and bottom-up strategies for HIV-prevention research using community assets and resources to enhance efforts to end the HIV epidemic.
The center will be based in St. Louis and initially will focus on building relationships within the city and county. Over the longer term, the center will expand into outlying counties to address the state’s significant rural epidemic as well. Dima Dandachi, MD, the medical director for the Columbia/Boone County Public Health and Human Services Department in central Missouri and the medical director of the HIV/AIDS treatment and prevention program at University of Missouri Health Care, sits on the center’s scientific working group to help guide research priorities.
The center aims to support HIV research at all levels, from laboratory experiments to community program pilots. To ensure that research funded by the center will answer the questions most critical to public health efforts and to people living with HIV, projects will be selected by a committee composed of people from academic and nonacademic organizations.
“Ending the HIV epidemic in the Midwest region demands that we, the public health communities, scientific communities as well as everyday citizens and persons living with HIV, all work together as partners and leaders,” Iwelunmor said.
About Washington University School of Medicine
WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,900 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 56% in the last seven years. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,900 faculty physicians practicing at 130 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.
Originally published on the School of Medicine website
